Skip to content

A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis

Orthopaedic Manual Physical Therapy Versus Corticosteroid Injections for Osteoarthritis of the Knee

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01427153
Acronym
SMART
Enrollment
156
Registered
2011-09-01
Start date
2012-08-31
Completion date
2019-05-31
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

knee osteoarthritis, physical therapy, corticosteroid, treatment

Brief summary

The purpose of this study is to compare an orthopaedic manual physical therapy (OMPT) approach to a corticosteroid injection approach for the management of knee osteoarthritis.

Detailed description

The purpose of this study is to compare a commonly offered clinical approach of a series of intra-articular steroid injections to an orthopaedic manual physical therapy (OMPT) approach consisting of manually applied passive movement and reinforcing exercise for the treatment of osteoarthritis of the knee (knee OA). A second purpose is to validate a clinical prediction rule (CPR) for patients unlikely to respond to the orthopaedic manual physical therapy approach in a pre-planned secondary analysis of data from the randomized clinical trial. Aim 1: To see if there is a significant difference in pain and function lasting out to 1 year for patients that receive a clinical approach consisting of a series of intra-articular steroid injections compared to those that receive a clinical approach consisting of orthopaedic manual physical therapy. Aim 2: To validate a clinical prediction rule of characteristics identified in a previous preliminary study that predicted which patients with knee OA would be unlikely to respond to OMPT.

Interventions

OMPT consists of joint and soft-tissue mobilizations and the exercises that reinforce the manual techniques.

PROCEDURECorticosteroid Injection

Corticosteroid injection to the tibiofemoral joint

Sponsors

Brooke Army Medical Center
CollaboratorFED
Madigan Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
38 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All subjects must be eligible for care in the military health system * Meet Altman's clinical criteria for knee OA * Have English language skills sufficient to complete the WOMAC and GROC outcome instruments * Be 38 years of age or older

Exclusion criteria

* Steroid injections or physical therapy treatment for their knee in the past 12 months * Current or past history of rheumatoid arthritis or similar rheumatic condition * Current or past history of gout or pseudogout of the knee * Active infection in the knee within the past 12 months * Other physical ailment or condition that is typically more limiting or painful than their knee OA during activities such as sitting, standing, walking, or stair climbing * History of allergy or adverse effect to corticosteroids * Cannot speak/read English adequately to understand and provide consent to participate in the study * Pregnant or intending to become pregnant * Military service members pending a medical evaluation board, physical evaluation board, equivalent discharge process, or on medical hold to determine long-term disposition. For non-military personnel, anyone that is pending or undergoing any litigation for this condition. * Contraindication to receiving a corticosteroid injection (history of allergic or adverse reaction to steroid injection, history of multiple corticosteroid injections in that area even if not within last year, etc) * Unable to give informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Western Ontario McMasters Osteoarthritis Index (WOMAC)1 yearThe WOMAC is a self report questionnaire that asks patient to rate their pain, stiffness, and functional limitation associated with their condition. This instrument will provide important information about the self-reported pain and disability level of the patients in this study. The WOMAC is a recommended primary outcome measure in therapy trials of arthritic conditions, and is considered one of the most appropriate scales for trials evaluating knee osteoarthritis (OA). It is a reliable, valid, and responsive instrument widely used in clinical trials evaluating therapy for hip and knee OA

Secondary

MeasureTime frameDescription
Global Rating of Change (GROC)1 YearThe GROC questionnaire is a common, feasible, and useful method for assessing short term outcomes and overall changes in quality of life, and is a valid measurement of change in patient status in a variety of pain populations. The GROC has a 15-point scale with a change of positive three points or higher demonstrating clinically significant improvement in a patients perception of quality of life.
Alternate Step Test (AST)1 YearThe Alternate Step Test is an inexpensive and efficient measure of dynamic postural stability and mobility. The AST requires participants to alternate feet and step 8 times (4 times for each foot) onto a 18 cm stool or step as rapidly as possible Recent evidence involving community dwelling adults also suggests that the AST has acceptable test-retest reliability (ICC=0.78) and potential as a fall risk assessment measure.
Timed Up and Go Test (TUG)1 YearThe Timed Up and Go Test is a functional performance measure which directly evaluates an individual's ability to transfer, ambulate, and maintain balance during transitions. Individuals are timed on how quickly they can stand, walk 3 meters, turn around, and return to the chair and sit down. The TUG has good inter-rater and intra-rater reliability and validity for functional testing in older adults at risk for falls. The test is easy to administer and can be completed in two to three minutes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026